|Jan-Feb '04 | briefing | mail | don't say this | flakers' jargon | flaker creativity | articles | other places | archives | send mail | ed dewke | legal stuff | order | search | PsorChat | PsorChat Review | ©2001 Ed Dewke|
Trial Subject is Very Happy
I just saw a letter in your
files asking for information from anyone participating in a Humira
trial. I have been involved in
one of these trials since September. I
have had severe psoriasis since I was 13, and in those 40 years, I have
never been cleared until now. I
had moderately good results two years ago with Soriatane
(about 70% clearing), but had to discontinue due to serious side
effects (ulcerations on my feet, which made walking impossible).
Two weeks after starting Humira, I was 50% clear; after one month I
was 99% clear (only a few stubborn lesions remaining on my scalp).
This stuff is the real deal! I
give myself one subcutaneous injection weekly, which is really virtually
I only hope the FDA
will approve this miracle, and that the insurance companies will pay for
it. -Sandy T.
Thanks for this, Sandy.
Though Humira is just
beginning its trials as a P drug, it was approved in December, 2002, for
rheumatoid arthritis. It is
another “biologic” drug — manufactured in living tissue.
At this writing we have these biologics approved and available to
us: Enbrel, Amevive, and
An NPF background
article on Humira (a.k.a. Adalimumab) and the current trials can be found